Voyager Therapeutics Inc. (VYGR) Downgraded to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Voyager Therapeutics Inc ... s disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington’s disease ...
News Type: